Hudson Technologies, Inc.

HDSN Basic Materials Specialty Chemicals

Hudson Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $246.6 million, up 4.00% from fiscal 2024.

Revenue
−19.7%
EPS
−82.1%
Free cash flow
+43.4%

Quarter to September 2026, against a year earlier

4.22 0.13 +3.18%
Market cap
$172.1M
P/E
0.0×
Fwd P/E
33.2×
Dividend yield
—
F-score
4/9
Altman Z
4.56
Beneish M
−2.13
Dividend safety
n/a

Insider Decisions last twelve months

Bought, $m 8.08
Sold, $m 3.59
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — 9 1 3 2 4 1 —
Sell 1 — — — — — — — — — — —
Insider Ownership 13.85%

Capital & Financial Ratios $m

Size
Market Cap 172.14
Revenue ttm 242.33
Net income ttm (1.32)
Free cash flow ttm (31.58)
Net debt Q (35.26)
Valuation
P/E 0.00
Forward P/E 33.20
Price / sales 0.71
Forward P/S Powerpack
Price / FCF 0.00
Price / book 0.70
Financial health
Current ratio Q 3.40 (at or above 1.5: strong)
Debt / equity Q 0.00 (at or below 0.5: strong)
Interest coverage Q (22.14)
Growth
Revenue growth Q −19.71% (below 0%: shrinking)
Operating income growth Q −76.73% (below 0%: shrinking)
EPS, this year −70.27% (below 0%: weak)
EPS, next year A +120.45% (at or above 15%: strong)
Revenue, next year A +0.16%
EPS, past 5 yrs —
EPS, next 5 yrs A +5.95%

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

P/S against its own 10 years 27.80%
10-year low 10-year high
P/B against its own 10 years 8.14%
10-year low 10-year high
EV/Sales against its own 10 years 0.04%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 12 70 39 35
Receivables 31 20 23 35
Inventory 154 96 136 132
Other — — — —
205 196 211 218
2023 2024 2025 Q'26
Payables 23 9 21 —
ST’ Debt — — — —
Other — 2 — —
59 48 65 64

Compound Annual Growth %

10y 5y 3y
Sales 11.96% 10.81% (8.81%)
Cash Flow 0.00% 0.00% 0.00%
Earnings 13.34% 0.00% (45.65%)
Book Value 17.28% 43.06% 11.65%

Earnings Trends EPS, adjusted, against the consensus

EPS $

Mar Jun Sep Dec Year
’26 0.01 0.12 0.05 — —
’25 0.06 0.23 0.27 (0.20) 0.37
’24 0.20 0.20 0.17 (0.06) 0.52
’23 0.33 0.41 0.29 0.08 1.10
’22 0.63 0.84 0.62 0.11 2.20
’21 (0.02) 0.24 0.34 0.13 0.69
’20 (0.07) 0.06 0.00 (0.11) (0.12)
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 60 78 59 — —
’25 55 73 74 44 247
’24 65 75 62 35 237
’23 77 90 76 45 289
’22 84 104 90 47 325
’21 34 61 61 38 193
’20 36 48 41 22 148
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (13) 7 10 — —
’25 14 6 9 (33) (3)
’24 (1) 42 30 21 92
’23 11 11 22 15 59
’22 5 29 26 3 63
’21 (5) (3) 16 (9) (1)
’20 (4) 6 17 (8) 12
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (14) 6 10 — —
’25 13 6 7 (34) (8)
’24 (2) 41 29 19 87
’23 10 10 21 14 55
’22 5 28 25 1 59
’21 (5) (4) 16 (11) (3)
’20 (4) 6 17 (9) 10
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 105 140 167 162 148 193 325 289 237 247 242 +9.9% 247 259 282 +4.6%
Gross margin, % 29.47 27.06 (4.42) 10.59 23.99 37.18 50.09 38.58 27.71 25.18 21.00 (4.3) pt
EBT 17 12 (57) (25) (5) 33 117 70 32 23 2 +3.1%
EBT margin, % 16.37 8.55 (34.45) (15.60) (3.65) 17.33 36.03 24.16 13.51 9.20 0.64 (7.2) pt
Net income 11 11 (56) (26) (5) 32 104 52 24 17 (1) +5.1%
Per share, $
Per share, $ Revenue 3.09 3.36 3.92 3.80 3.46 4.40 7.23 6.37 5.23 5.66 5.76 +6.9%
Earnings 0.31 0.27 (1.31) (0.61) (0.12) 0.74 2.31 1.15 0.54 0.38 (0.02) +2.3%
Cash flow 0.27 0.44 0.86 0.79 0.27 (0.03) 1.40 1.29 2.03 (0.07) (0.67) n/m
Capex (0.05) (0.02) (0.03) (0.02) (0.03) (0.04) (0.08) (0.08) (0.12) (0.12) (0.08) +9.6%
Free cash flow 0.22 0.42 0.83 0.77 0.24 (0.07) 1.31 1.21 1.91 (0.19) (0.75) n/m
Book value 3.28 2.96 1.63 1.06 0.95 1.62 3.89 5.04 5.42 5.58 5.83 +6.1%
Shares, m 34 42 42 43 43 44 45 45 45 44 43 +2.8%
Valuation, ×
Valuation, × P/E 23.97 22.21 0.00 0.00 0.00 6.00 4.23 12.09 10.53 18.51 0.00 9.8
P/S 2.56 1.85 0.23 0.26 0.32 1.01 1.35 2.18 1.07 1.21 0.71 1.2
P/B 2.41 2.10 0.55 0.93 1.15 2.74 2.51 2.76 1.03 1.23 0.70 1.7
EV/Sales 2.24 3.01 0.99 0.85 0.90 1.47 1.47 2.24 0.90 1.17 0.69 1.5
EV/FCF 31.11 24.37 4.70 4.21 13.00 (89.60) 8.07 11.80 2.46 (35.11) (5.28) (2.5)
Cash, $m
Cash, $m Operating cash flow 9 18 36 34 12 (1) 63 59 92 (3) (28) n/m
Capex (2) (1) (1) (1) (1) (2) (4) (4) (5) (5) (3) +12.6%
Free cash flow 8 17 35 33 10 (3) 59 55 87 (8) (32) n/m
Balance, $m
Balance, $m Working capital 98 114 63 28 24 56 124 146 148 146 154 +4.6%
Net debt (34) 162 128 96 86 90 38 (12) (70) (39) (35) +1.8%
Shareholders’ equity 112 123 69 45 41 71 175 229 246 243 246 +9.0%
Returns, %
Returns, % ROA 10.25 5.03 (20.25) (12.70) (3.05) 17.10 42.52 18.36 8.14 5.37 (0.40) (4.9) pt
ROIC 15.10 3.31 (13.53) (6.97) 2.92 16.44 38.62 22.59 10.42 5.69 0.27 (9.4) pt
ROE 13.18 9.48 (57.78) (45.38) (12.15) 57.83 84.45 25.89 10.28 6.81 (0.51) (6.4) pt
People
People Employees 137 262 243 234 221 217 232 237 238 281 — +8.3%
Revenue/emp, $m 0.77 0.54 0.69 0.69 0.67 0.89 1.40 1.22 1.00 0.88 — +1.5%
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 5 Nov 2026

Hudson Technologies, Inc. vs peers in Specialty Chemicals (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
GEVO Gevo, Inc. $301.6M — (loss-making) — (loss-making) +7.11% (above 0%: growing) n/m −167.47% (below 0%: shrinking) 42.58% (369.25%) Compare
ALTO Alto Ingredients, Inc. $284.7M 5.4× 9.7× +12.48% (above 0%: growing) n/m +1,443.92% (above 0%: growing) 6.77% 3.51% Compare
ASPI ASP Isotopes Inc. $263.7M — (loss-making) — (loss-making) +327.63% (above 0%: growing) n/m −182.92% (below 0%: shrinking) 28.89% (667.48%) Compare
FF FutureFuel Corp. $236.9M — (loss-making) — (loss-making) +120.69% (above 0%: growing) n/m +4,245.38% (above 0%: growing) 19.08% 14.29% Compare
OEC Orion S.A. $235.7M — (loss-making) — (loss-making) +4.86% (above 0%: growing) n/m +64.87% (above 0%: growing) 19.20% 4.82% Compare
CMT Core Molding Technologies Inc $186.3M 25.6× 44.8× +54.42% (above 0%: growing) −18.18% (below 0%: shrinking) −3,170.52% (below 0%: shrinking) 14.83% 1.76% Compare
HDSN Hudson Technologies, Inc. $172.1M — (loss-making) 33.2× −19.71% (below 0%: shrinking) −82.14% (below 0%: shrinking) +43.42% (above 0%: growing) 24.91% 5.47%
ACNT Ascent Industries Co. $122.4M — (loss-making) — (loss-making) +37.61% (above 0%: growing) −89.23% (below 0%: shrinking) −97.54% (below 0%: shrinking) 21.62% (1.02%) Compare
FEAM 5E Advanced Materials, Inc. $93.8M — (loss-making) — — n/m +17.79% (above 0%: growing) 0.00% 0.00% Compare
Median of peers $236.3M — — +37.61% — −39.88% 19.14% 0.88%

All 61 Specialty Chemicals stocks →

Pay and ownership Proxy statement filed 24 April 2026

Ownership

Directors and executive officers, together 1.90%
Ernest Lazarus 9.40%
Hartree Partners, LP 9.00%
BlackRock, Inc. 7.50%
Westerly Capital Management, LLC 6.10%
Dimensional Fund Advisors LP 5.10%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Hudson Technologies, Inc. (HDSN) Latest News

29 Oct

Impact 3 · · StockStory
Impact 3 · · MarketBeat
Impact 3 · · The Motley Fool transcript

6 Oct

6 May

Impact 3 · · MarketBeat
stockrow.com/HDSN · Data as of Nov 5, 2026 · For information only; not investment advice. · © 2026 stockrow.com